Ashwani Singal
Professor of Medicine University of Louisville
Ashwani Singal, M.D., is a transplant hepatolgist with training from Mount Sinai VAMC (Bronx, NY), UTMB (Galveston, TX) and Mayo Clinic (Richester, MN). He has fifteen years of experience in patient care and clinical research in patients with liver disease. He also has a passion for trainee education with clinical research interests in alcohol-associated liver disease, hepato-renal syndrome, NASH and porphyria.
Seminars
Thursday 16th April 2026
Unlocking the Potential of GLP-1s to Treat Addiction & Substance Use Disorders to Reduce Cravings & Impulsivity to Provide a Novel Treatment Option
10:00 am
- Modulating brain reward circuits to reduce cravings and impulsivity, offering a novel, non-addictive therapeutic option for substance use disorders
- Expanding the therapeutic scope of GLP-1s to offer a new treatment for addiction to help address a major public health crisis with a new mechanism
- Integrating GLP-1 therapy with behavioural interventions to enhance treatment efficacy, leading to better patient outcomes and a higher rate of long-term recovery
Thursday 16th April 2026
Fire-Side Discussion: Repurposing GLP-1s to Treat Alzheimer’s & Parkinson’s to Improve Cognitive Function & Reduce Neuroinflammation to Create a New Therapeutic Avenue
12:00 pm
- Diversifying treatment opportunities by investigating GLP-1s for new indications like neurological disorders and addiction to unlock their full therapeutic potential and expand their use beyond cardiometabolic health
- Providing new hope for patients by researching next-generation applications to create therapeutic options for conditions with limited treatments
- Expanding the clinical horizon with a wider range of applications for GLP-1s to establish these therapies as a foundational class of drugs for modern medicine
